Capsule structure containing an atsubanori polysaccharide complex

The atsuanori polysaccharide complex in a dual-shell capsule structure addresses the issues of joint inflammation and pain by incorporating specific functional microparticles, enhancing joint lubrication and reducing discomfort during exercise.

JP3251996UActive Publication Date: 2025-07-11ZEWEI YINGYI CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2025001552U
Authority / Receiving Office
JP · JP
Patent Type
Utility models
Current Assignee / Owner
Priority Date
2025-02-13
Filing Date
2025-05-16
Publication Date
2025-07-11
Estimated Expiration
2035-05-16

AI Technical Summary

Technical Problem

Existing solutions fail to effectively prevent inflammatory reactions, improve joint lubrication, and reduce pain during exercise.

Method used

A capsule structure containing an atsuanori polysaccharide complex with a dual-shell design and functional microparticles comprising atsuanori polysaccharide, black cicada protein, calcium alginate, non-denatured type II collagen, and vitamin D3, which are sealed in a closed accommodation space to maintain effectiveness.

Benefits of technology

The capsule structure effectively prevents inflammatory reactions, enhances joint lubrication, and reduces pain during exercise by utilizing the synergistic effects of its components.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0003251996000001_ABST
    Figure 0003251996000001_ABST
Patent Text Reader

Abstract

The present invention provides a capsule structure containing an atsukanori polysaccharide complex. 【Solution means】The capsule structure S includes a capsule main body 10 and a plurality of functional microparticles. The capsule main body includes a first capsule shell 11 and a second capsule shell 12, and the first capsule shell and the second capsule shell are fitted together to form a closed accommodation space 13. The functional microparticles 20 are filled in the accommodation space of the capsule main body. The composition of the functional microparticles includes atsukanori polysaccharide, black shijimi protein, and seaweed calcium.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a capsule structure, and particularly to a capsule structure containing an atsuanori polysaccharide complex.

Background Art

[0002] With the progress of science and technology and the improvement of medical resources, the average lifespan of humans has been continuously increasing, and the trend of aging has become a global phenomenon. Whether it is the elderly who maintain the quality of life or the young who pursue sports performance and physical health, how to maintain joint flexibility, reduce obstacles in activities, and effectively prevent degenerative problems has become an important issue in the health management of all age groups.

[0003] Based on years of manufacturing experience in related fields, the inventor of the present invention actively conducts research on innovative auxiliary products that can prevent inflammation, promote joint lubrication, and reduce discomfort after exercise through a thorough study of the mechanisms of joint function and inflammation. After considering all conditions, the present invention has been achieved.

Summary of the Invention

Problems to be Solved by the Invention

[0004] The technical problem to be solved by the present invention is to provide a capsule structure containing an atsuanori polysaccharide complex in view of the deficiencies of the prior art. The capsule structure containing an atsuanori polysaccharide complex according to the present invention can effectively prevent and suppress the inflammatory reaction, improve the lubrication degree of joints, and reduce the pain during exercise.

Means for Solving the Problems

[0005] To solve the above technical problems, one of the technical means adopted by the present invention is to provide a capsular structure containing an atsubanori polysaccharide complex, which includes a capsule body and a plurality of functional microparticles. The capsule body includes a first capsule shell and a second capsule shell. The first capsule shell and the second capsule shell are fitted together to form a closed accommodation space, and the functional microparticles are filled in the accommodation space of the capsule body. Here, the composition of the functional microparticles includes atsubanori polysaccharide, black cicada protein, and calcium alginate.

[0006] In an embodiment of the present invention, the first capsule shell includes a first closed end and a first fitting end opposite to the first closed end. The second capsule shell includes a second closed end and a second fitting end opposite to the second closed end. The outer diameter of the second fitting end corresponds to the inner diameter of the first fitting end of the first capsule shell, and the second capsule shell is fitted inside the first capsule shell.

[0007] In an embodiment of the present invention, the composition of the plurality of functional microparticles further includes non-denatured type II collagen and vitamin D3.

[0008] In an embodiment of the present invention, the content of the atsubanori polysaccharide is 30 mg to 200 mg, the content of the black cicada protein is 30 mg to 200 mg, and the content of the calcium alginate is 20 mg to 150 mg.

[0009] In an embodiment of the present invention, the content of the non-denatured type II collagen is 5 mg to 40 mg, and the content of the vitamin D3 is 1 mg to 10 mg.

Advantages of the Invention

[0010] As one of the advantageous effects of the present invention, the capsule structure containing the atsubanori polysaccharide complex according to the present invention is formed such that "the first capsule shell and the second capsule shell are fitted to each other to surround a closed accommodation space" and "a plurality of functional microparticles are filled in the accommodation space of the capsule main body, and the composition of the plurality of functional microparticles includes atsubanori polysaccharide, black shijimi protein, and calcium alginate". Due to such technical features, it can effectively prevent and suppress inflammatory reactions, improve joint lubrication, and reduce pain during exercise.

Brief Description of the Drawings

[0011]

Figure 1

Figure 2

Figure 3

Modes for Carrying Out the Invention

[0012] To better understand the features and technical content of the present invention, please refer to the following detailed description and drawings related to the present invention. However, the provided drawings are for reference and explanation purposes only and are not intended to limit the present invention.

[0013] Hereinafter, the implementation mode of the "capsule structure containing atsuanori polysaccharide complex" will be described according to specific specified embodiments, and those skilled in the art can understand the advantages and effects of the present invention based on the content disclosed in this specification. The present invention can be implemented or applied by other different specific embodiments, and for each detail in this specification, various modifications and changes can be made based on different viewpoints and uses without departing from the concept of the present invention. Also, as described in advance, the accompanying drawings of the present invention are simple schematic descriptions and are not drawn based on actual sizes. The technical content of the present invention will be described in more detail based on the following embodiments, but the protection scope of the present invention will not be limited by the disclosed content. Also, the term "or" used in this specification may include any one or a combination of more than one of the related items according to the actual situation.

[0014] [First Embodiment] In the first embodiment of the present invention, a composition is provided for effectively preventing and suppressing inflammatory reactions, improving joint lubricity, and reducing pain during exercise. The composition mainly contains atsuanori polysaccharide, black cicada protein, and seaweed calcium. Here, in the composition having an effective amount, the content of atsuanori polysaccharide is 30 mg to 200 mg, the content of black cicada protein is 30 mg to 200 mg, and the content of seaweed calcium is 20 mg to 150 mg.

[0015] Specifically, the seaweed in the present invention is Sarcodia suieae, which has high nutritional value, is rich in Sarcodia suieae polysaccharides and dietary fiber, and has effects such as anti - inflammation, anti - thrombosis, and anti - tumor. The protein of the black clam has effects such as lowering blood pressure, promoting wound healing, relieving fatigue, and antioxidant effects, and the nutritional value of the black clam is more than 7 times that of ordinary clams. Seaweed calcium is a natural plant calcium, and compared with other common artificial synthetic calcium health products (such as calcium carbonate and calcium lactate), the human absorption rate of seaweed calcium is higher. In animal experiments, when a composition (500 mg / kg) consisting of Sarcodia suieae polysaccharides and black clam was given to arthritic mice for 10 days, it was observed that the swelling of the joints of the arthritic mice decreased, and the proteoglycan (an important protective component of joints) in the joints was less likely to be lost. Furthermore, the composition consisting of Sarcodia suieae polysaccharides and black clam protein can effectively reduce inflammatory factors such as TNF - α and IFN - γ that cause joint tissue damage. That is, the composition consisting of Sarcodia suieae polysaccharides and black clam protein is effective in protecting joints, reducing discomfort, and increasing joint flexibility.

[0016] It should be noted that in the first embodiment of the present invention, the composition for preventing and suppressing inflammatory reactions, improving joint lubrication, and reducing pain during exercise further contains non - denatured type II collagen and vitamin D3. In the composition having an effective amount, the content of the non - denatured type II collagen is 5 mg to 40 mg, and the content of the vitamin D3 is 1 mg to 10 mg, but the present invention is not limited to the above - mentioned examples.

[0017] [Second Embodiment] As shown in FIGS. 1 to 3, in the second embodiment of the present invention, a Sarcodia suieae polysaccharide complex - containing capsule structure S including a capsule body 10 and a plurality of functional microparticles 20 is provided.

[0018] The capsule body 10 includes a first capsule shell 11 and a second capsule shell 12. The first capsule shell 11 and the second capsule shell 12 are fitted to each other to form a closed accommodation space 13. The functional microparticles 20 are filled in the accommodation space 13 of the capsule body 10, but the present invention is not limited to the examples mentioned above.

[0019] Specifically, the first capsule shell 11 includes a first closed end 111 and a first fitting end 112 opposite to the first closed end 111. The second capsule shell 12 includes a second closed end 121 and a second fitting end 122 opposite to the second closed end 121. The outer diameter of the second fitting end 122 corresponds to the inner diameter of the first fitting end 112 of the first capsule shell 11, and the second capsule shell 12 is fitted inside the first capsule shell 11 to form a closed accommodation space 13 for filling the functional microparticles 20. The functional microparticles 20 may be in the form of powder grains, granules, or powders.

[0020] Specifically, the functional microparticles 20 may be further processed by embedding technology and freeze-drying technology, so that the functional microparticles 20 can be formed to be coated in multiple layers by layers such as a damage prevention layer, a dehydration prevention layer, an antioxidant layer, an oligosaccharide layer, and a polysaccharide layer. When actually applied, the functional microparticles 20 are digested by the gastric acid and choline of the human body and finally released when reaching the intestine.

[0021] In this embodiment, the plurality of the functional microparticles 20 are a composition for effectively preventing and suppressing the inflammatory reaction according to the first embodiment, improving the lubrication degree of joints, and reducing pain during exercise. That is, the plurality of the functional microparticles 20 at least contain atsuwanori polysaccharide, black mayfly protein, and seaweed calcium. That is, the composition of the functional microparticles 20 is an atsuwanori polysaccharide complex. Here, each of the capsule structures S contains a composition having an effective amount. In the composition, the content of atsuwanori polysaccharide is 30 mg to 200 mg, the content of black mayfly protein is 30 mg to 200 mg, and the content of seaweed calcium is 20 mg to 150 mg. In another embodiment, the plurality of the functional microparticles 20 may further contain non-denatured type II collagen and vitamin D3. Here, the content of non-denatured type II collagen may be 5 mg to 40 mg, and the content of vitamin D3 may be 1 mg to 10 mg, but the present invention is not limited thereto.

[0022] As a point to be explained, the accommodation space 13 in the capsule body 10 can provide a storage environment suitable for the functional microparticles 20. When the functional microparticles 20 are sealed in the accommodation space 13, dry air may be filled so that the functional microparticles 20 are not easily deteriorated. However, the above example is only one of the feasible embodiments, and the present invention is not limited thereto.

[0023] [Third Embodiment] In this embodiment, 11 patients with discomfort in joints were administered one capsule of the capsule structure S of the second embodiment of the present invention per day. It should be noted that in this embodiment, the composition of the functional microparticles contains atsuwanori polysaccharide, black mayfly protein, seaweed calcium, non-denatured type II collagen, and vitamin D3. After 30 days, 9 out of the patients felt that the flexibility of their joints had improved and the discomfort in their joints had been reduced.

[0024] [Advantageous Effects According to Embodiment] As one of the advantageous effects of the present invention, the capsule structure containing the atsukanori polysaccharide complex according to the present invention has the technical features that "the first capsule shell and the second capsule shell are fitted to each other to form a closed accommodation space" and "a plurality of functional microparticles are filled in the accommodation space of the capsule body, and the composition of the plurality of functional microparticles includes atsukanori polysaccharide, black rice shrimp protein, and calcium alginate", thereby effectively preventing and suppressing inflammatory reactions, improving joint lubricity, and reducing pain during exercise.

[0025] The content disclosed above is merely a preferred implementable embodiment of the present invention, and the scope of the claims of the present invention is not limited thereto. Therefore, any equivalent technical changes made using the content of the specification and drawings of the present invention are all included in the scope of the claims for utility model registration of the present invention.

Explanation of Reference Numerals

[0026] S... Capsule structure 10… Capsule body 11… First capsule shell 111… First closed end 112… First fitting end 12… Second capsule shell 121… Second closed end 122… Second fitting end 13… Accommodation space 20… Functional microparticles

Claims

1. An atsubanol polysaccharide complex-containing capsule structure comprising a capsule body and a plurality of functional microparticles, wherein the capsule body comprises a first capsule shell and a second capsule shell, and the first capsule shell and the second capsule shell are fitted together to form a closed accommodation space therearound, and the functional microparticles are filled in the accommodation space of the capsule body, and the composition of the functional microparticles is characterized by containing atsubanol polysaccharide, black rice shrimp protein, and algal calcium. An atsubanol polysaccharide complex-containing capsule structure.

2. The first capsule shell includes a first closed end and a first fitting end opposite to the first closed end, the second capsule shell includes a second closed end and a second fitting end opposite to the second closed end, and the outer diameter of the second fitting end corresponds to the inner diameter of the first fitting end of the first capsule shell, and the second capsule shell is fitted inside the first capsule shell. The atsubanol polysaccharide complex-containing capsule structure according to Claim 1.

3. The composition of the plurality of functional microparticles further includes non-denatured type II collagen and vitamin D3. The atsubanol polysaccharide complex-containing capsule structure according to Claim 1.

4. The content of the atsubanol polysaccharide is 30 mg to 200 mg, the content of the black rice shrimp protein is 30 mg to 200 mg, and the content of the algal calcium is 20 mg to 150 mg. The atsubanol polysaccharide complex-containing capsule structure according to Claim 1.

5. The content of the non-denatured type II collagen is 5 mg to 40 mg, and the content of the vitamin D3 is 1 mg to 10 mg. The atsubanol polysaccharide complex-containing capsule structure according to Claim 3.